Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stereotactic Body Radiation Therapy (SBRT)”

810 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 810 results

Testing effectiveness (Phase 2)WithdrawnNCT03778879
What this trial is testing

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Who this might be right for
Adenocarcinoma of the PancreasPancreas Cancer
Alan Katz
Early research (Phase 1)Study completedNCT00946673
What this trial is testing

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain CancerNeoplasm MetastasisLung Cancer+1 more
Stanford University 17
Not applicableUnknownNCT05160818
What this trial is testing

Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases

Who this might be right for
Brain MetastasesResection Cavity
Technical University of Munich 126
Not applicableLooking for participantsNCT07585929
What this trial is testing

Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

Who this might be right for
Stage IIIC
All India Institute of Medical Sciences 150
Testing effectiveness (Phase 2)WithdrawnNCT04889066
What this trial is testing

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Brain Metastases from Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Not applicableNot Yet RecruitingNCT06852001
What this trial is testing

Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

Who this might be right for
Brain MetastasisSRS
Tianjin Medical University Cancer Institute and Hospital 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592612
What this trial is testing

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Who this might be right for
Hepatocellular CarcinomaOligoprogression
Sun Yat-sen University 70
Not applicableLooking for participantsNCT06949254
What this trial is testing

PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial

Who this might be right for
High Risk Prostate Cancer
Istituto Clinico Humanitas 49
Not applicableStudy completedNCT00243841
What this trial is testing

Dose Escalation Study for Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Indiana University 77
Testing effectiveness (Phase 2)Study completedNCT02704156
What this trial is testing

SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 170
Not applicableLooking for participantsNCT07407608
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca 58
Early research (Phase 1)Active Not RecruitingNCT05678010
What this trial is testing

AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Who this might be right for
Solid TumorMetastatic Solid TumorSolid Carcinoma+3 more
Memorial Sloan Kettering Cancer Center 54
Not applicableStudy completedNCT01347307
What this trial is testing

Stereotactic Body Radiotherapy for Spine Tumors

Who this might be right for
Spinal MetastasesVertebral MetastasesBenign Spinal Tumors+6 more
Mercy Research 38
Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Not applicableActive Not RecruitingNCT03585621
What this trial is testing

Stereotactic Body Radiation Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Toronto Sunnybrook Regional Cancer Centre 24
Large-scale testing (Phase 3)Looking for participantsNCT07058428
What this trial is testing

FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma

Who this might be right for
Multiple Brain Metastases in Lung Adenocarcinoma
Sun Yat-Sen University Cancer Center 258
Not applicableLooking for participantsNCT06551909
What this trial is testing

Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)

Who this might be right for
Glioblastoma
IRCCS San Raffaele 30
Testing effectiveness (Phase 2)WithdrawnNCT03029416
What this trial is testing

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

Who this might be right for
Neoplasm MetastasisCancerRadiation Therapy Complication
Ronald McGarry
Not applicableLooking for participantsNCT06493734
What this trial is testing

Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

Who this might be right for
Klatskin Tumor
Erasmus Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02446093
What this trial is testing

Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic Adenocarcinoma
Candel Therapeutics, Inc. 54
Load More Results